 |
市場調查報告書
商品編碼
2075910
去活化脊髓灰質炎和狂犬病疫苗市場：依疫苗類型、去活化方法、年齡層、通路和地區分類Inactivated Polio And Rabies Vaccines Market, by Vaccine, By Method of Inactivation, By Age Group, by Distribution Channel and by Region |
||||||
價格
簡介目錄
預計到 2026 年，去活化脊髓灰質炎和狂犬疫苗市場規模將達到 13.62 億美元，到 2033 年將達到 19.945 億美元。預計從 2026 年到 2033 年，該市場將以 5.6% 的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2025 | 2026年市場規模： | 13.62億美元 |
| 歷史數據時期： | 2020年至2024年 | 預測期： | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率： | 5.60% | 2033年市場規模預測： | 19.945億美元 |
這種疫苗由1型、2型和3型去活化脊髓灰質炎（IPV）組成，可提供針對脊髓灰質炎的主動免疫。肌肉注射去活化脊髓灰質炎病毒疫苗（IPV）可活化免疫系統，刺激產生針對脊髓灰質炎的抗體。狂犬病疫苗用於預防狂犬病。目前市面上有許多安全有效的狂犬病疫苗。這些疫苗可用於在接觸狂犬病毒（通常由犬咬傷或蝙蝠咬傷引起）之前和之後的一段時間內預防狂犬病。世界各國政府都在積極致力於根除脊髓灰質炎，這推動了對IPV的需求成長。此外，北美等某些地區脊髓灰質炎發生率的上升也促進了該領域的成長。脊髓灰質炎和狂犬病發病率的上升推動了對去活化脊髓灰質炎和狂犬病疫苗的需求，預計這將促進全球去活化脊髓灰質炎和狂犬病疫苗市場的成長。
市場動態
預計在預測期內，市場參與者的研發活動將推動全球去活化脊髓灰質炎和狂犬病疫苗市場的成長。例如，2021年3月，美國生技公司Ocugen Inc.發表了其狂犬病、脊髓灰質炎和新冠疫苗的正面初步數據。這種在臨床實驗疫苗採用了與數十年來用於生產脊髓灰質炎疫苗相同的Vero細胞生產平台。
本研究的主要特點：
- 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
- 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
- 本研究根據以下參數介紹了全球去活化脊髓灰質炎和狂犬病疫苗市場主要參與者的概況：公司概況、產品系列、主要亮點、財務績效和策略。
- 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
- 這份《全球去活化脊髓灰質炎和狂犬病疫苗市場》報告旨在為業界的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
- 相關人員可以透過分析全球去活化脊髓灰質炎和狂犬病疫苗市場中使用的各種策略矩陣來簡化決策過程。
目錄
第1章：研究目標與前提條件
- 分析目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章：市場動態、監管與趨勢分析
- 市場動態
- 促進因素
- 抑制因子
- 市場機遇
- 影響分析
- 近期產品發布
- 流行病學
- 併購和合作
- 監管趨勢
- 主要進展
- PEST分析
第4章 全球去活化脊髓灰質炎及狂犬病疫苗市場：依產品類型分類，2021-2033年
- 引進去活化脊髓灰質炎疫苗
- 引入去活化狂犬疫苗
第5章 全球去活化脊髓灰質炎及狂犬病疫苗市場：依去活化方法分類，2021-2033年
- 溶劑/界面活性劑法
- 輻射定律
- pH濃度
- 熱去活化
- 其他
第6章 全球去活化脊髓灰質炎及狂犬病疫苗市場：依年齡層別分類，2021-2033年
- 兒童
- 成人
第7章 全球去活化脊髓灰質炎及狂犬病疫苗市場：依通路分類，2021-2033年
- 政府
- 私人的
第8章 全球去活化脊髓灰質炎和狂犬病疫苗市場：按地區分類，2021-2033年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
- 中東
- GCC
- 以色列
- 其他中東國家
- 非洲
- 北非
- 中非
- 南非
第9章：公司簡介
- 巴拉特生物技術公司
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- BIO-MED
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 印度血清研究所私人有限公司
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- Kedrion Biopharma Inc.
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- GlaxoSmithKline Plc
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 比爾德霍芬生物製品
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- Merck &Co., Inc.
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 輝瑞
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 卡迪拉醫療保健有限公司
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 賽諾菲巴斯德印度私人有限公司
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- Chiron Behring Vaccines Private Ltd
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- Zoetis Inc.
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 禮來公司。
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 勃林格殷格翰國際股份有限公司
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- Indian Immunologicals Ltd
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- YS製藥
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 伯納生技公司
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- 諾華疫苗
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
- Medimmune LLC
- 公司簡介
- 產品系列
- 財務業績
- 近期趨勢和最新信息
- 策略
第10章
- 參考
- 調查方法
簡介目錄
Product Code: CMI3581
Inactivated Polio And Rabies Vaccines Market is estimated to be valued at USD 1,362.0 Mn in 2026 and is expected to reach USD 1,994.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,362.0 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.60% | 2033 Value Projection: | USD 1,994.5 Mn |
A vaccine consisting of inactivated poliovirus (IPV) types 1, 2, and 3, with active immunizing activity against poliomyelitis. Upon intramuscular vaccination, inactivated poliovirus vaccine (IPV) activates the immune system to develop antibodies against polio viruses. The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for some time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite. Governments around the world are actively working towards eradicating polio, which has led to increased demand for IPV. Additionally, the rising prevalence of polio in certain regions, such as the North America region, has also contributed to the growth of this segment. The increasing prevalence of polio and rabies diseases is driving the growth of the inactivated polio and the rabies vaccine associated with the virus is expected to boost the global inactivated polio and rabies vaccine market growth.
Market Dynamics
Research and development activity by market players is expected to spur the global inactivated polio and rabies vaccines market growth over the forecast period. For Instance, in March 2021, Ocugen Inc., is a biotech company in the U.S., announced positive top-line data for rabies, polio and COVID-19 Vaccine. Investigational vaccine that uses the same vero cell manufacturing platform that had been used in the production of polio vaccines for decades.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global inactivated polio and rabies vaccines market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Bharat Biotech., BIO-MED, Serum Institute of India Pvt. Ltd., Kedrion Biopharma Inc. GlaxoSmithKline plc., Bilthoven Biologicals, Merck & Co., Inc., Pfizer Inc, Cadila Healthcare Limited, Sanofi Pasteur India Pvt Ltd, Chiron Behring Vaccines Private Ltd ,Zoetis Inc., Elanco.,Boehringer Ingelheim International GmbH,Indian Immunologicals Ltd, Wyeth pharmaceuticals, Berna Biotech Ltd., Novartis Vaccines Ltd and Medimmune LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global inactivated polio and rabies vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inactivated polio and rabies vaccines market
Detailed Segmentation:
- Global Inactivated Polio And Rabies Vaccines Market, By Product Type:
- Inactivated Polio Vaccine
- Inactivated Rabies Vaccine
- Global Inactivated Polio And Rabies Vaccines Market, By Method of Inactivation (Revenue, USD Mn, 2021 - 2033)
- Radiation Method
- Heat Inactivation
- Solvent Detergent Method
- pH Concentration
- Health Activation
- Others
- Global Inactivated Polio And Rabies Vaccines Market, By Age Group (Revenue, USD Mn, 2021 - 2033)
- Pediatrics
- Adults
- Global Inactivated Polio And Rabies Vaccines Market, By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Government
- Private
- Global Inactivated Polio And Rabies Vaccines Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Bharat Biotech.
- BIO-MED
- Serum Institute of India Pvt. Ltd.
- Kedrion Biopharma Inc.
- GlaxoSmithKline plc..
- Bilthoven Biologicals.
- Merck & Co.
- Pfizer Inc.
- Cadila Healthcare Limited
- Sanofi Pasteur India Pvt Ltd
- Chiron Behring Vaccines Private Ltd
- Zoetis Inc.
- Boehringer Ingelheim International GmbH
- Indian Immunologicals Ltd
- Wyeth pharmaceuticals
- Berna Biotech Ltd.
- Novartis Vaccines Ltd
- Medimmune LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product type
- Market Snapshot, By Method of Activation
- Market Snapshot, By Age Group
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Inactivated Polio and Rabies Vaccines Market, By Product Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Inactivated Polio Vaccine Introduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Inactivated Rabies Vaccine Introduction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
5. Global Inactivated Polio and Rabies Vaccines Market, By Method of Inactivation, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Solvent Detergent Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Radiation Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- pH Concentration
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Heat Inactivation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
6. Global Inactivated Polio and Rabies Vaccines Market, By Age Group, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatrics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
7. Global Inactivated Polio and Rabies Vaccines Market, By Distribution Channel, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Government
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
- Private
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Million)
8. Global Inactivated Polio and Rabies Vaccines Market, By Region, 2021 - 2033 (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- North America
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of Inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of Inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Vaccine, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Method of inactivation, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Age Group, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033 (US$ Mn)
- North Africa
- Central Africa
- South Africa
9. Company Profiles
- Bharat Biotech
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- BIO-MED
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Serum Institute of India Pvt. Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Kedrion Biopharma Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GlaxoSmithKline plc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bilthoven Biologicals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Merck & Co., Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Cadila Healthcare Limited
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Sanofi Pasteur India Pvt Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Chiron Behring Vaccines Private Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Zoetis Inc.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Elanco.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Boehringer Ingelheim International GmbH
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Indian Immunologicals Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Wyeth pharmaceuticals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Berna Biotech Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Novartis Vaccines Ltd
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Medimmune LLC
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
10. Section
- References
- Research Methodology
- About us and Sales Contact
02-2729-4219
+886-2-2729-4219
人用狂犬疫苗市場：依疫苗類型、給藥途徑、劑型、通路和最終用戶分類－2026-2032年全球市場預測
百日咳疫苗市場規模、佔有率和成長分析：按產品類型、疫苗類型、應用、最終用戶和地區分類－2026-2033年產業預測
人類預防性疫苗市場：按疫苗類型、技術平台、應用和地區分類。單價疫苗（EB病毒）市場按應用和地區分類2025-2030 年全球脊髓灰質炎聯合疫苗市場預測（按疫苗類型、接種途徑、技術、開發階段和最終用戶分類）
全球百日咳疫苗市場規模（按疫苗類型、年齡層、分銷管道、區域覆蓋範圍和預測）全球人類狂犬病疫苗市場規模（按細胞株類型、應用、分銷管道、區域覆蓋範圍和預測）全球腦炎疫苗市場規模（按菌株、最終用戶、區域覆蓋範圍和預測）預防疫苗市場按疫苗類型、疾病類型、分銷管道和地區分類TCV 疫苗市場按疫苗品牌、通路和地區分類
▼